TrialAntioxidants & redox signaling2014
Targeting chelatable iron as a therapeutic modality in Parkinson's disease.
David Devos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
342 papers cite itlatest 60 shown
this paperpooled ittrialcites it